Advancing Glaucoma Research on Capitol Hill

Alliance for Vision Research recently convened a Congressional Briefing on glaucoma, bringing together researchers, clinicians, advocates, and policymakers to highlight the latest scientific advances and the urgent need for sustained federal investment in vision research.

While more intimate in size, the briefing delivered meaningful impact—fostering powerful conversations and connections between experts and congressional staff. Speakers shared insights on emerging research, the challenges patients face, and the critical role of the National Eye Institute in driving progress toward earlier detection, better treatments, and ultimately preventing vision loss.

A central theme throughout the discussion was clear: glaucoma remains a leading cause of irreversible blindness, affecting millions of Americans, and continued investment in research is essential to change that trajectory.

Through moments of shared experience and scientific exchange, the briefing reinforced the importance of connecting patient voices with policymakers. These conversations help ensure that decisions made on Capitol Hill reflect both the urgency of the need and the promise of discovery.

We are deeply grateful to our presenters, partners, and sponsors who made this briefing possible. Together, we are advancing a unified message—one that keeps vision research at the forefront of national priorities and moves us closer to a future where blindness can be prevented.

In case you missed it, watch the full briefing.